Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
Kawthar Mohamed, Niloufar Yazdanpanah, Amene Saghazadeh, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104490-104490
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Use of molecular docking computational tools in drug discovery
Francesca Stanzione, Ilenia Giangreco, Jason C. Cole
Progress in medicinal chemistry (2021), pp. 273-343
Closed Access | Times Cited: 395
Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Autoimmune complications of COVID‐19
Niloufar Yazdanpanah, Nima Rezaei
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 54-62
Open Access | Times Cited: 149
A systematic review of pregnant women with COVID-19 and their neonates
Mona Mirbeyk, Amene Saghazadeh, Nima Rezaei
Archives of Gynecology and Obstetrics (2021)
Open Access | Times Cited: 132
Drug repositioning: Progress and challenges in drug discovery for various diseases
Yi Hua, Xiaowen Dai, Yuan Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114239-114239
Open Access | Times Cited: 129
Drug combination therapy for emerging viral diseases
Zeenat A. Shyr, Yu‐Shan Cheng, Donald C. Lo, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 10, pp. 2367-2376
Open Access | Times Cited: 118
COVID-19 and Its Global Economic Impact
Zahra Kolahchi, Manlio De Domenico, Lucina Q. Uddin, et al.
Advances in experimental medicine and biology (2021), pp. 825-837
Closed Access | Times Cited: 83
The role of type I interferon in the treatment of COVID‐19
Fatemeh Sodeifian, Mahsa Nikfarjam, Naghmeh Kian, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 63-81
Open Access | Times Cited: 76
Information technology in emergency management of COVID-19 outbreak
Afsoon Asadzadeh, Saba Pakkhoo, Mahsa Mirzaei Saeidabad, et al.
Informatics in Medicine Unlocked (2020) Vol. 21, pp. 100475-100475
Open Access | Times Cited: 75
VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares
Ling Shen, Fu‐Xing Liu, Li Huang, et al.
Computers in Biology and Medicine (2021) Vol. 140, pp. 105119-105119
Open Access | Times Cited: 67
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2723-2723
Open Access | Times Cited: 66
Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
Zahra Molavi, Sara Razi, Seyed Amir Mirmotalebisohi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111544-111544
Open Access | Times Cited: 64
The New Era of Drug Discovery: The Power of Computer-aided Drug Design (CADD)
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 11, pp. 951-955
Closed Access | Times Cited: 61
In silico vaccine design: A tutorial in immunoinformatics
Dominic D. Martinelli
Healthcare Analytics (2022) Vol. 2, pp. 100044-100044
Open Access | Times Cited: 57
REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction
Yaowen Gu, Si Zheng, Qijin Yin, et al.
Computers in Biology and Medicine (2022) Vol. 150, pp. 106127-106127
Closed Access | Times Cited: 41
Recent advance in the development of N-heterocyclic derivatives as anti-SARS-CoV-2 inhibitors: A review
Walid Ettahiri, Mohamed Adardour, Siham Alaoui, et al.
Phytochemistry Letters (2024) Vol. 61, pp. 247-269
Closed Access | Times Cited: 10
Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19)
Niloufar Yazdanpanah, Amene Saghazadeh, Nima Rezaei
Reviews in the Neurosciences (2020) Vol. 31, Iss. 7, pp. 691-701
Open Access | Times Cited: 55
In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis
Prinsa R. Nagar, Normi D. Gajjar, Tejas M. Dhameliya
Journal of Molecular Structure (2021) Vol. 1246, pp. 131190-131190
Open Access | Times Cited: 50
Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies
Ashimiyu Durojaiye, John‐Ross D. Clarke, George A. Stamatiades, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 12, pp. 4547-4554
Open Access | Times Cited: 49
Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study
R.P. Vivek-Ananth, S. Krishnaswamy, Areejit Samal
Molecular Diversity (2021) Vol. 26, Iss. 1, pp. 429-442
Open Access | Times Cited: 36
Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions
Nesrine Rizk, Rima Moghnieh, Nisrine Haddad, et al.
Antibiotics (2021) Vol. 10, Iss. 11, pp. 1320-1320
Open Access | Times Cited: 36
Natural Products for the Prevention and Control of the COVID-19 Pandemic: Sustainable Bioresources
Rajeev K. Singla, Xuefei He, Hitesh Chopra, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 34
Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
Tejas M. Dhameliya, Prinsa R. Nagar, Normi D. Gajjar
Molecular Diversity (2022) Vol. 26, Iss. 5, pp. 2775-2792
Open Access | Times Cited: 25
Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies
Francesco Napolitano, Xiaopeng Xu, Xin Gao
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2
Vikas Kumar, Shraddha Parate, Sanghwa Yoon, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top